Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Loss-of-function mutations in parkin are the predominant cause of familial Parkinson's disease. We previously reported that parkin-/- mice exhibit nigrostriatal deficits in the absence of nigral degeneration. Parkin has been shown to function as an E3 ubiquitin ligase. Loss of parkin function, therefore, has been hypothesized to cause nigral degeneration via an aberrant accumulation of its substrates. Here we employed a proteomic approach to determine whether loss of parkin function results in alterations in abundance and/or modification of proteins in the ventral midbrain of parkin-/- mice. Two-dimensional gel electrophoresis followed by mass spectrometry revealed decreased abundance of a number of proteins involved in mitochondrial function or oxidative stress. Consistent with reductions in several subunits of complexes I and IV, functional assays showed reductions in respiratory capacity of striatal mitochondria isolated from parkin-/- mice. Electron microscopic analysis revealed no gross morphological abnormalities in striatal mitochondria of parkin-/- mice. In addition, parkin-/- mice showed a delayed rate of weight gain, suggesting broader metabolic abnormalities. Accompanying these deficits in mitochondrial function, parkin-/- mice also exhibited decreased levels of proteins involved in protection from oxidative stress. Consistent with these findings, parkin-/- mice showed decreased serum antioxidant capacity and increased protein and lipid peroxidation. The combination of proteomic, genetic, and physiological analyses reveal an essential role for parkin in the regulation of mitochondrial function and provide the first direct evidence of mitochondrial dysfunction and oxidative damage in the absence of nigral degeneration in a genetic mouse model of Parkinson's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, mitophagy deficiency favored by ablation of Prkn (Palacino et al, 2004; Pickrell et al, 2015) or Pink1 (Gautier et al, 2008) sensitizes mice to oxidative stress, while worsening neural damage when combined with mitochondrial dysfunction (mitochondrial DNA [mtDNA] mutator‐prkn/parkin‐KO mice) (Pickrell et al, 2015).”
From Autophagy in major human diseases (2021) · cites this paper as Palacino et al, 2004
In the citing paper
“Both Pink1 and Parkin knockout mice exhibit increased ROS levels and mitochondrial dysfunction (43, 44), and persistent increased ROS is one of the important factors in accelerating cellular senescence (42, 45).”
From Impaired mitophagy leads to cigarette smoke stress‐induced cellular senescence: implications for chronic obstructive pulmonary disease (2015) · cites this paper as [43]
Citations
Cites
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,396
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants
Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., & Pallanck, L. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737556100 · Cited by 1,203
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.
Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., & Mizuno, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2696 · Cited by 981
Research works printed but not linked: 5
- Jenner, 1996, Neurology, 47, 5161
- Koller, 1986, Neurology, 36
- Darios, 2003, Hum. Mol. Genet., 12, 517, 10.1093/hmg/ddg044 · doi:10.1093/hmg/ddg044 · Paper page
- Klose, 1999, Methods Mol. Biol., 112, 67
- Dubin, 1989, Mol. Cell. Biol., 9, 1083
Cited by
Items 401–500 of 1,000
Even, B., Fayad‐Kobeissi, S., Gagliolo, J., Motterlini, R., Boczkowski, J., Foresti, R., & Dagouassat, M. (2018) · Aging Cell · doi:10.1111/acel.12837 · Cited by 70
Exploring the Role of Ubiquitin–Proteasome System in Parkinson's Disease
Behl, T., Kumar, S., Althafar, Z. M., Sehgal, A., Singh, S., Sharma, N., Badavath, V. N., Yadav, S., Bhatia, S., Al‐Harrasi, A., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02851-1 · Cited by 70
Hong, X., Liu, J., Zhu, G., Zhuang, Y., Suo, H., Wang, P., Huang, D., Xu, J., Huang, Y., Yu, M., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt501 · Cited by 69
Undamatla, R., Fagunloye, O. G., Chen, J., Edmunds, L. R., Murali, A., Mills, A., Xie, B., Pangburn, M. M., Sipula, I., Gibson, G., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-34710-x · Cited by 68
Wilhelmus, M. M. M., Nijland, P. G., Drukarch, B., de Vries, H. E., & van Horssen, J. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.040 · Cited by 68
Wang, X., Feng, S., Wang, Z., Yuan, Y., Chen, N., & Zhang, Y. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00914-2 · Cited by 68
Mitochondrial dysfunction induced by knockdown of mortalin is rescued by Parkin
Yang, H., Zhou, X., Liu, X., Yang, L., Chen, Q., Zhao, D., Zuo, J., & Liu, W. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.05.116 · Cited by 68
Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity
Perez, F. A., Curtis, W. R., & Palmiter, R. D. (2005) · BMC Neuroscience · doi:10.1186/1471-2202-6-71 · Cited by 67
Ahlskog, J. E. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.09.010 · Cited by 67
Wang, X., Feng, S., Wang, Y., Yuan, Y., Li, Z., Chen, N., Wang, Z., & Zhang, Y. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01039-w · Cited by 67
Tokarew, J. M., Kodsi, D. N. E., Lengacher, N. A., Fehr, T. K., Nguyen, A., Shutinoski, B., O’Nuallain, B., Jin, M., Khan, J. M., Ng, A. C., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02285-4 · Cited by 67
Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease
Imbriani, P., Martella, G., Bonsi, P., & Pisani, A. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105851 · Cited by 67
Early‐Onset Parkinsonism Is a Manifestation of the PPP2R5D p. E200K Mutation
Kim, C. Y., Wirth, T., Hubsch, C. A., Nemeth, A. H., Okur, V., Anheim, M., Drouot, N., Tranchant, C., Rudolf, G., Chelly, J., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25863 · Cited by 67
Ekholm-Reed, S., Goldberg, M. S., Schlossmacher, M. G., & Reed, S. I. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00535-13 · Cited by 66
Self-citationPINK, PANK, or PARK? A clinicians' guide to familial parkinsonism
Healy, D. G., Abou‐Sleiman, P. M., & Wood, N. W. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00905-6 · Cited by 68
Fitzgerald, J. C., & Plun‐Favreau, H. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06708.x · Cited by 66
Huynh, D. P., Nguyen, D., Pulst‐Korenberg, J., Brice, A., & Pulst, S.-M. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.09.009 · Cited by 66
PARK2 Mutation Causes Metabolic Disturbances and Impaired Survival of Human iPSC-Derived Neurons
Bogetofte, H., Jensen, P., Ryding, M., Schmidt, S. I., Okarmus, J., Ritter, L., Worm, C. S., Hohnholt, M. C., Azevedo, C., Roybon, L., et al. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00297 · Cited by 66
Acute and long-term proteome changes induced by oxidative stress in the developing brain
Kaindl, A. M., Sifringer, M., Zabel, C., Nebrich, G., Wacker, M. A., Felderhoff‐Mueser, U., Endesfelder, S., von der Hagen, M., Stefovska, V. G., Klose, J., et al. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401796 · Cited by 66
Self-citationVulnerability of mesostriatal dopaminergic neurons in Parkinson’s disease
González-Hernández, T. (2010) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2010.00140 · Cited by 65
Szalárdy, L., Klivènyi, P., Zádori, D., Fülöp, F., Toldi, J., & Vécsei, L. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800167365 · Cited by 67
Converging environmental and genetic pathways in the pathogenesis of Parkinson's disease
Burbulla, L. F., & Krüger, R. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.04.005 · Cited by 65
Differential Analysis of Saccharomyces cerevisiae Mitochondria by Free Flow Electrophoresis
Zischka, H., Braun, R. J., Marantidis, E., Büringer, D., Bornhövd, C., Hauck, S. M., Demmer, O., Gloeckner, C. J., Reichert, A. S., Madeo, F., et al. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t600018-mcp200 · Cited by 65
Potential Role of Epigenetic Mechanism in Manganese Induced Neurotoxicity
Tarale, P., Chakrabarti, T., Sivanesan, S., Naoghare, P. K., Bafana, A., & Krishnamurthi, K. (2016) · BioMed Research International · doi:10.1155/2016/2548792 · Cited by 65
Parkin Is Protective against Proteotoxic Stress in a Transgenic Zebrafish Model
Fett, M. E., Pilsl, A., Paquet, D., van Bebber, F., Haass, C., Tatzelt, J., Schmid, B., & Winklhofer, K. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011783 · Cited by 65
Mitochondrial Dynamics and Parkinson's Disease: Focus on Parkin
Lim, K.-L., Ng, X.-H., Grace, L. G.-Y., & Yao, T.-P. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4105 · Cited by 64
Age related mitochondrial degenerative disorders in humans
Reeve, A. K., Krishnan, K. J., & Turnbull, D. M. (2008) · Biotechnology Journal · doi:10.1002/biot.200800066 · Cited by 64
Liang, Y., Cui, L., Gao, J., Zhu, M., Zhang, Y., & Zhang, H. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02375-0 · Cited by 64
Wilkaniec, A., Lenkiewicz, A. M., Babiec, L., Murawska, E., Jęśko, H. M., Cieślik, M., Culmsee, C., & Adamczyk, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.591475 · Cited by 63
Kumar, P., Pradhan, K., Ramani, K., Ambasta, R. K., & Querfurth, H. W. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07588.x · Cited by 63
Mutations that affect mitochondrial functions and their association with neurodegenerative diseases
Dhillon, V. S., & Fenech, M. F. (2013) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2013.09.001 · Cited by 63
Transgenic rodent models of Parkinson’s disease
Harvey, B. K., Wang, Y., & Hoffer, B. J. (2009) · Acta neurochirurgica. Supplementum · doi:10.1007/978-3-211-78205-7_15 · Cited by 63
Liver-targeted Nano-MitoPBN normalizes glucose metabolism by improving mitochondrial redox balance
Wu, M., Liao, L., Jiang, L., Zhang, C., Gao, H., Qiao, L., Liu, S., & Shi, D. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119457 · Cited by 63
MicroRNAs and the metabolic hallmarks of aging
Victoria, B., Nunez Lopez, Y. O., & Masternak, M. M. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.12.021 · Cited by 62
Mitochondrial dynamics and neuronal fate in Parkinson's disease
Santos, D., & Cardoso, S. M. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.05.002 · Cited by 63
Martin, L. J. (2007) · Reviews in the Neurosciences · doi:10.1515/revneuro.2007.18.2.115 · Cited by 62
Parkin modulates heteroplasmy of truncated mtDNA in Caenorhabditis elegans
Valenci, I., Yonai, L., Bar-Yaacov, D., Mishmar, D., & Ben‐Zvi, A. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.11.001 · Cited by 62
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Flores-Ponce, X., & Velasco, I. (2024) · Metabolomics · doi:10.1007/s11306-024-02181-4 · Cited by 62
Involvement of Mitochondria in Parkinson’s Disease
Choong, C., & Mochizuki, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242317027 · Cited by 62
Model fusion: The next phase in developing animal models for parkinson’s disease
Manning-Bog, A., & Langston, J. W. (2007) · Neurotoxicity Research · doi:10.1007/bf03033569 · Cited by 62
Saini, N., Oelhafen, S., Hua, H., Georgiev, O., Schaffner, W., & Büeler, H. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.011 · Cited by 61
Mitochondrial ATP Synthase is a Target of Oxidative Stress in Neurodegenerative Diseases
Ebanks, B., & Chakrabarti, L. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.854321 · Cited by 62
Haylett, W. L., Swart, C., van der Westhuizen, F. H., Dyk, H. C. V., van der Merwe, L., van der Merwe, C., Loos, B., Carr, J. A., Kinnear, C. J., & Bardien, S. (2016) · Parkinson s Disease · doi:10.1155/2016/1819209 · Cited by 60
Naoi, M., Maruyama, W., & Shamoto‐Nagai, M. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02150-w · Cited by 60
Parkin in Parkinson’s Disease and Cancer: a Double-Edged Sword
Wahabi, K., Perwez, A., & Rizvi, M. M. A. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0879-1 · Cited by 60
Parkin deficiency disrupts calcium homeostasis by modulating phospholipase C signalling
Matton, A., Dehvari, N., Pérez‐Manso, M., Craig, K. J. T., Karpilovski, E., Cookson, M., Cowburn, R. F., & Cedazo-Mínguez, Á. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07201.x · Cited by 60
Synaptic dysfunction in genetic models of Parkinson's disease: A role for autophagy?
Plowey, E. D., & Chu, C. T. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.10.011 · Cited by 59
Arduíno, D. M., Esteves, A. R., & Cardoso, S. M. (2011) · Parkinson's Disease · doi:10.4061/2011/767230 · Cited by 59
Twenty years since the discovery of the parkin gene
Hattori, N., & Mizuno, Y. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1742-7 · Cited by 59
Potential Therapeutic Benefits of Maintaining Mitochondrial Health in Peripheral Neuropathies
Areti, A., Yerra, V. G., Komirishetty, P., & Kumar, A. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666151126215358 · Cited by 60
Ari-1 Regulates Myonuclear Organization Together with Parkin and Is Associated with Aortic Aneurysms
Tan, K. L., Haelterman, N. A. T., Kwartler, C. S., Regalado, E. S., Lee, P.-T., Nagarkar-Jaiswal, S., Guo, D., Duraine, L., Wangler, M. F., Bamshad, M. J., et al. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.03.020 · Cited by 59
Battaglia, G., Farrace, M. G., Mastroberardino, P. G., Viti, I., Fimia, G. M., BEEUMEN, J. V., Devreese, B. V., Melino, G., Molinaro, G., Busceti, C. L., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04140.x · Cited by 59
Recent progress in the role of autophagy in neurological diseases
Meng, T., Lin, S., Zhuang, H., Huang, H., He, Z., Hu, Y., Gong, Q., & Feng, D. (2019) · Cell Stress · doi:10.15698/cst2019.05.186 · Cited by 58
“A deficit in striatal synaptic plasticity and evoked dopamine release response was found in the striatum of mice where Parkin was deleted [136], and impaired activity of mitochondria was also observed in striatal neuron [137].”
Background(2020) · International Review of Neurobiology · doi:10.1016/bs.irn.2020.02.010 · Cited by 58
Yasuda, T., & Mochizuki, H. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0486-8 · Cited by 58
Weiduschat, N., Mao, X., Beal, M. F., Nirenberg, M. J., Shungu, D. C., & Henchcliffe, C. (2013) · Journal of Neuroimaging · doi:10.1111/jon.12074 · Cited by 58
Parkin targets NOD2 to regulate astrocyte endoplasmic reticulum stress and inflammation
Singh, K., Han, K., Tilve, S., Wu, K., Geller, H. M., & Sack, M. N. (2018) · Glia · doi:10.1002/glia.23482 · Cited by 58
Are heat shock proteins therapeutic target for Parkinson's disease?
Luo, G., Chen, S., & Le, W.-D. (2007) · International Journal of Biological Sciences · doi:10.7150/ijbs.3.20 · Cited by 58
Protein stability and aggregation in Parkinson's disease
Robinson, P. A. (2008) · Biochemical Journal · doi:10.1042/bj20080295 · Cited by 58
Potential Future Neuroprotective Therapies for Neurodegenerative Disorders and Stroke
Tarawneh, R. M., & Galvin, J. E. (2010) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2009.12.003 · Cited by 59
Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson’s disease
Romaní-Aumedes, J., Canal, M., Martín‐Flores, N., Sun, X., Pérez-Fernández, V., Wewering, S., Fernández‐Santiago, R., Ezquerra, M., Pont‐Sunyer, C., Lafuente, A., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.333 · Cited by 59
Wang, X., Zhang, J., Xiu, C., Yang, J., Fang, J., & Lei, Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7151946 · Cited by 57
The Beneficial Role of Thiamine in Parkinson Disease
Lương, K. V. Q., & Nguyễn, L. T. H. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12078 · Cited by 57
Tissue- and Cell-Specific Mitochondrial Defect in Parkin-Deficient Mice
Damiano, M., Gautier, C. A., Bulteau, A.-L., Ferrando-Miguel, R., Gouarne, C., Paoli, M. G., Pruss, R., Auchère, F., L'Hermitte-Stead, C., Bouillaud, F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099898 · Cited by 57
Shim, J. H., Yoon, S. H., Kim, K., Han, J., Ha, J., Hyun, D. H., Paek, S. H., Kang, U. J., Zhuang, X., & Son, J. H. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.05.013 · Cited by 57
Khan, M. S., Nasiripour, S., & Bopassa, J. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136416 · Cited by 58
Parkinson's disease and glucose metabolism impairment
Chen, L., Wang, C., Qin, L., & Zhang, H. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00467-8 · Cited by 58
Use of viral vectors to create animal models for Parkinson's disease
Löw, K., & Aebischer, P. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.038 · Cited by 56
Wu, M., Zhang, C., Xie, M., Zhen, Y., Lai, B., Liu, J., Qiao, L., Liu, S., & Shi, D. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.03.029 · Cited by 56
Nugent, S., Mothersill, C. E., Seymour, C. B., McClean, B., Lyng, F. M., & Murphy, J. E. J. (2010) · International Journal of Radiation Biology · doi:10.3109/09553002.2010.486019 · Cited by 55
Autophagy and LRRK2 in the Aging Brain
Albanese, F., Novello, S., & Morari, M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01352 · Cited by 55
Wilkaniec, A., Cieślik, M., Murawska, E., Babiec, L., Gąssowska-Dobrowolska, M., Pałasz, E., Jęśko, H. M., & Adamczyk, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113959 · Cited by 55
Gorgone, G., Currò, M., Ferlazzo, N., Parisi, G., Parnetti, L., Belcastro, V., Tambasco, N., Rossi, A., Pisani, F., Calabresi, P., et al. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8174-1 · Cited by 55
Genetic Mouse Models of Neurodegenerative Diseases
Trancikova, A. K., Ramonet, D., & Moore, D. J. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-384878-9.00012-1 · Cited by 54
Parkin affects mitochondrial function and apoptosis in neuronal and myogenic cells
Kuroda, Y., Mitsui, T., Kunishige, M., & Matsumoto, T. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.06.201 · Cited by 54
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2018) · NeuroMolecular Medicine · doi:10.1007/s12017-018-8486-x · Cited by 55
Klein, R. L., Dayton, R. D., Henderson, K. M., & Petrucelli, L. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.03.001 · Cited by 55
Esteve-Rudd, J., Campello, L., Herrero, M. T., Cuenca, N., & Martín‐Nieto, J. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.019 · Cited by 53
Sheline, C. T., Zhu, J., Zhang, W., Shi, C., & Cai, A. (2012) · Neurodegenerative Diseases · doi:10.1159/000336558 · Cited by 53
Hwang, C. J., Kim, Y., Son, D. J., Park, M. H., Choi, D., Park, P., Hellström, M., Han, S., Oh, K., Park, E., et al. (2016) · Redox Biology · doi:10.1016/j.redox.2016.12.008 · Cited by 52
Mitophagy and neurodegeneration: The zebrafish model system
Wager, K., & Russell, C. (2013) · Autophagy · doi:10.4161/auto.25082 · Cited by 52
Parkin absence accelerates microtubule aging in dopaminergic neurons
Cartelli, D., Amadeo, A., Calogero, A. M., Casagrande, F., Gregorio, C. D., Gioria, M., Kuzumaki, N., Costa, I., Sassone, J., Ciammola, A., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.09.010 · Cited by 52
Edmunds, L. R., Xie, B., Mills, A. M., Huckestein, B. R., Undamatla, R., Murali, A., Pangburn, M. M., Martin, J. L., SIPULA, I. J., Kaufman, B. A., et al. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101051 · Cited by 51
What have we learned from Drosophila models of Parkinson’s disease?
Guo, M. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)84001-4 · Cited by 51
Building the mitochondrial proteome
Cruz, S. D., Parone, P. A., & Martinou, J. (2005) · Expert Review of Proteomics · doi:10.1586/14789450.2.4.541 · Cited by 51
Value of genetic models in understanding the cause and mechanisms of Parkinson’s disease
Moore, D. J., & Dawson, T. M. (2008) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-008-0045-7 · Cited by 50
Jeong, D.-W., Cho, I. T., Kim, T. S., Bae, G. W., Kim, I. H., & Kim, I. Y. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-9004-7 · Cited by 50
Moszczyńska, A., Saleh, J., Zhang, H., Vukusic, B., Lee, F. J. S., & Liu, F. (2007) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-0037-0 · Cited by 50
Genetic factors involved in the pathogenesis of Parkinson's disease
Lee, F. J. S., & Liu, F. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.02.001 · Cited by 50
Balance is the challenge – The impact of mitochondrial dynamics in Parkinson’s disease
Burbulla, L. F., Krebiehl, G., & Krüger, R. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02354.x · Cited by 50
Pisani, A., Martella, G., Tscherter, A., Costa, C., Mercuri, N. B., Bernardi, G., Shen, J., & Calabresi, P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.001 · Cited by 50
Self-citationLee, S., She, J., Deng, B., Kim, J.-J., de Andrade, M., Na, J., Sun, Z., Wampfler, J. A., Cunningham, J. M., Wu, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9954 · Cited by 50
Saini, N., Georgiev, O., & Schaffner, W. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05207-11 · Cited by 49
“In agreement with this notion, Parkin deficient flies suffer from mitochondrial malfunction (24, 45, 48), which distorts muscle structure and causes severe locomotor defects and an inability to fly (24, 48).”
BackgroundParkin-mediated mitophagy and autophagy flux disruption in cellular models of MERRF syndrome
Paz, M. V., Povea-Cabello, S., Villalón-García, I., Álvarez-Córdoba, M., Suarez-Rivero, J. M., Talaverón-Rey, M., Jackson, S., Falcón‐Moya, R., Moreno, A. R., & Sánchez-Alcázar, J. A. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165726 · Cited by 49
Belin, A. C., Björk, B. F., Westerlund, M., Galter, D., Sydow, O., Lind, C., Pernold, K., Rosvall, L., Håkansson, A., Winblad, B., et al. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.05.010 · Cited by 48
Watanabe, H., Dijkstra, J. M., & Nagatsu, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042009 · Cited by 48
Bertolin, G., Jacoupy, M., Traver, S., Ferrando-Miguel, R., Saint-Georges, T., Grenier, K., Ardila-Osorio, H., Mp, M., Takahashi, H., Lees, A. J., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2014.224 · Cited by 48
Mitophagy and Oxidative Stress in Cancer and Aging: Focus on Sirtuins and Nanomaterials
Vernucci, E., Tomino, C., Molinari, F., Limongi, D., Aventaggiato, M., Sansone, L., Tafani, M., & Russo, M. A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6387357 · Cited by 48
Reversible generalized dystonia and encephalopathy from thiamine transporter 2 deficiency
Serrano, M., Rebollo, M., Depienne, C., Rastetter, A., Fernández‐Álvarez, E., Muchart, J., Martorell, L., Artuch, R., Obeso, J. A., & Pérez‐Dueñas, B. (2012) · Movement Disorders · doi:10.1002/mds.25008 · Cited by 48
Zinc supplement greatly improves the condition of parkin mutant Drosophila
Saini, N., & Schaffner, W. (2010) · Biological Chemistry · doi:10.1515/bc.2010.052 · Cited by 47
Metadata
- Authors
- Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., Klose, J., & Shen, J.
- Affiliations
- Brigham and Women's Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Charité – Universitätsmedizin Berlin (DE)
- Corresponding author
- Shen, Jie
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-04
- Volume
- 279
- Issue
- 18
- Pages
- 18614-18622
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2140647923
- Cited by
- 995
- References
- 66
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 34 · 2023: 29 · 2022: 27 · 2021: 44 · 2020: 51 · 2019: 39 · 2018: 41 · 2017: 32 · 2016: 41 · 2015: 41 · 2014: 42 · 2013: 60 · 2012: 49
- FWCI
- 42.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6031 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Keywords
- Parkin, Parkinson's disease, mitochondrial dysfunction, oxidative stress, E3 ubiquitin ligase, nigrostriatal pathway, complex I, cytochrome c oxidase, respiratory capacity, lipid peroxidation, protein peroxidation, serum antioxidant capacity, metabolic abnormalities
- MeSH terms
- Animals, Antioxidants, Basal Ganglia, Mitochondria, Oxidative Phosphorylation, Parkinson Disease, Protein Processing, Post-Translational, Weight Gain, Reactive Oxygen Species, Mice, Knockout, Oxidative Stress, Cell Respiration, Mitochondrial Proteins, Mitochondrial Diseases, Ubiquitin-Protein Ligases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.